Most Read Articles
2 days ago
The types of bariatric surgery differentially affect the risk of developing acute pancreatitis postoperatively, such that the risk is greater in patients who undergo vertical sleeve gastrectomy vs Roux-en-Y gastric bypass surgery, according to a study. Risk factors include younger age and presence of gallstones.
6 days ago
Elderly adults using hypoglycaemic glucose-lowering drugs, such as insulin and glinides, have an excess risk of hospitalization for serious trauma, a recent study has found.
6 days ago
Rather than the presence or type or urinary incontinence, increasing severity of urinary incontinence correlates with increased depression, anxiety and stress among treatment-seeking women with lower urinary tract symptoms (LUTS), suggests a study.
Roshini Claire Anthony, 4 days ago

Overweight or obese patients taking lorcaserin as an appetite suppressant may have the added benefit of a reduced risk of incident diabetes, according to results of the CAMELLIA-TIMI 61* trial presented at EASD 2018.

Use of early psychosis intervention services reduces mortality rates

15 May 2018

Mortality rates are four times lower among individuals with first-episode psychosis who used early psychosis intervention (EPI) services than those with first-episode psychosis who did not use these services, reports a new study. Use of EPI services also leads to better outcomes across several healthcare system indicators.

Over the 2-year period after admission to the EPI programme, individuals who used EPI services had substantially lower rates of all-cause mortality (hazard ratio [HR], 0.24; 95 percent CI, 0.11–0.53). However, there was no significant between-group difference in self-harm (HR, 0.86; 0.18–4.24) and suicide (HR, 0.73; 0.29–1.80).

In addition, use of EPI services resulted in lower rates of emergency department presentation (HR, 0.71; 0.60–0.83) but higher rates of hospitalization (HR, 1.42; 1.18–1.71). When EPI care was stepped down to medical management after 2 years, these benefits were not observed.

“These findings support the effectiveness of EPI services for the treatment of first-episode psychosis in the larger context of the overall healthcare system,” the authors said.

In this study, health administrative data was used to construct a retrospective cohort of incident cases of nonaffective psychosis in the catchment area of the Prevention and Early Intervention Program for Psychoses in London, Ontario, between 1997 and 2013.

The authors linked this cohort to primary data from the same programme to identify those who used EPI services. Cox proportional hazards models were used to compare outcomes for individuals who used EPI services and those who did not.

“EPI programmes improve clinical and functional outcomes for people with first-episode psychosis, [but] less is known about the impact of these programmes on the larger healthcare system,” the authors said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
The types of bariatric surgery differentially affect the risk of developing acute pancreatitis postoperatively, such that the risk is greater in patients who undergo vertical sleeve gastrectomy vs Roux-en-Y gastric bypass surgery, according to a study. Risk factors include younger age and presence of gallstones.
6 days ago
Elderly adults using hypoglycaemic glucose-lowering drugs, such as insulin and glinides, have an excess risk of hospitalization for serious trauma, a recent study has found.
6 days ago
Rather than the presence or type or urinary incontinence, increasing severity of urinary incontinence correlates with increased depression, anxiety and stress among treatment-seeking women with lower urinary tract symptoms (LUTS), suggests a study.
Roshini Claire Anthony, 4 days ago

Overweight or obese patients taking lorcaserin as an appetite suppressant may have the added benefit of a reduced risk of incident diabetes, according to results of the CAMELLIA-TIMI 61* trial presented at EASD 2018.